Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Levocarnitine |
Is a |
False |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
L-Carnitine adverse reaction |
Causative agent (attribute) |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
L-Carnitine allergy |
Causative agent (attribute) |
False |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carnitine deficiency products |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing levocarnitine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
L-Carnitine 30% pediatric solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
L-Carnitine 1g/10mL single-dose oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
L-Carnitine 1g injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely levocarnitine 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levocarnitine 330 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levocarnitine 200mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levocarnitine 1g/5mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levocarnitine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levocarnitine 1g/10mL sugar free oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing levocarnitine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
L-Carnitine allergy |
Causative agent (attribute) |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levocarnitine 330 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levocarnitine 330 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levocarnitine 330 mg oral tablet |
Has precise active ingredient |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levocarnitine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only levocarnitine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levocarnitine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levocarnitine 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levocarnitine 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levocarnitine 300 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levocarnitine 300 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levocarnitine 200 mg/mL solution for injection |
Has precise active ingredient |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levocarnitine 200 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levocarnitine 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levocarnitine 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levocarnitine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |